300584 海辰药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.6354.0514.0013.7483.414
总资产报酬率 ROA (%)1.1332.8072.7992.6872.500
投入资产回报率 ROIC (%)1.2783.1193.0272.9042.674

边际利润分析
销售毛利率 (%)78.44582.51283.15181.34675.304
营业利润率 (%)9.4846.9138.2897.5885.718
息税前利润/营业总收入 (%)10.2538.0359.9388.6996.665
净利润/营业总收入 (%)10.1876.0707.9637.0136.102

收益指标分析
经营活动净收益/利润总额(%)120.519172.871121.168112.609125.643
价值变动净收益/利润总额(%)-9.804-55.5730.0080.1063.229
营业外收支净额/利润总额(%)-1.4781.927-1.896-4.254-4.605

偿债能力分析
流动比率 (X)1.0671.0421.0650.9431.193
速动比率 (X)0.8280.8340.8100.7390.991
资产负债率 (%)27.13628.21329.11329.90826.537
带息债务/全部投入资本 (%)21.28320.90222.98322.70818.337
股东权益/带息债务 (%)366.711374.754329.079333.256433.349
股东权益/负债合计 (%)257.563243.668239.916234.355276.827
利息保障倍数 (X)11.3008.1455.5136.1225.558

营运能力分析
应收账款周转天数 (天)108.09799.521138.243136.316101.316
存货周转天数 (天)211.422248.855353.993271.296165.152